Valuation: BOIRON

Market Cap 460M 531M 431M 393M 739M 50.65B 751M 5.07B 1.98B 25.36B 1.99B 1.95B 84.57B P/E 2024
41x
P/E 2025 16.1x
Enterprise Value 412M 476M 386M 352M 662M 45.38B 673M 4.54B 1.78B 22.72B 1.79B 1.75B 75.77B EV / Sales 2024
0.85x
EV / Sales 2025 0.95x
Free-Float
19.96%
Yield 2024
4.48%
Yield 2025 4.46%
1 day+1.53%
1 week-3.64%
Current month-3.28%
1 month-3.64%
3 months-5.02%
6 months-10.17%
Current year-12.54%
1 week 25.7
Extreme 25.7
27.2
1 month 25.7
Extreme 25.7
28
Current year 24.35
Extreme 24.35
30.95
1 year 20.85
Extreme 20.85
32.25
3 years 20.85
Extreme 20.85
56.5
5 years 20.85
Extreme 20.85
56.5
10 years 20.85
Extreme 20.85
92.91
Manager TitleAgeSince
Chief Executive Officer 57 2024-12-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 65 2011-06-30
Director/Board Member 54 2010-03-09
Director/Board Member 51 2013-05-22
Date Insider Type Main position Quantity % Market Cap.
10/29/23 Sell

Director

198,664 1.1323%
10/29/23 Sell

Director

462,964 2.6387%
10/29/23 Sell

Director

4,748 0.0271%
Change 5-day change 1-year change 3-year change Capi.($)
+1.53%-3.64%+24.71%-48.44% 531M
-0.55%-0.69%-9.65%-7.08% 13.37B
-1.21%-2.36%+3.99%+2.62% 5.01B
-0.04%-0.80%-31.72%-56.12% 5.06B
-0.53%+2.07%+4.22%-31.14% 4.16B
-0.19%-1.55%-13.19%-5.97% 3.66B
-1.79%-3.93%-5.97%+0.44% 3.44B
-1.42%-2.61%-6.07%+14.85% 3.39B
+0.44%+1.34%-13.09%-15.72% 2.48B
-9.22%-8.90%-11.69%+29.56% 1.71B
Average -1.30%-1.56%-5.85%-11.70% 4.28B
Weighted average by Cap. -0.97%-0.82%-8.89%-11.19%

Financials

2024 2025
Net sales 488M 563M 457M 417M 783M 53.67B 795M 5.37B 2.1B 26.88B 2.11B 2.07B 89.61B 501M 578M 470M 428M 805M 55.16B 817M 5.52B 2.16B 27.62B 2.17B 2.12B 92.1B
Net income 11.34M 13.08M 10.62M 9.69M 18.21M 1.25B 18.49M 125M 48.83M 625M 49.13M 48.06M 2.08B 32.64M 37.68M 30.58M 27.9M 52.45M 3.59B 53.25M 360M 141M 1.8B 141M 138M 6B
Net Debt -49.74M -57.41M -46.6M -42.51M -79.91M -5.48B -81.14M -548M -214M -2.74B -216M -211M -9.14B -47.86M -55.23M -44.84M -40.9M -76.89M -5.27B -78.07M -527M -206M -2.64B -207M -203M -8.8B
Logo BOIRON
Laboratoires BOIRON was founded in France almost a century ago, under the impetus of homeopathic doctors who wanted to benefit from the most reliable medicines possible. Homeopathic medicines have many advantages in that they can be prescribed and advised in first line whenever relevant, in both urban and hospital settings. All actions aim to contribute to major public health issues. Homeopathic medicines are obtained from substances called homeopathic strains, according to a manufacturing process described in the pharmacopoeia. These strains can be of plant, animal, mineral or chemical origin. There are two main families of homeopathic medicines: common name homeopathic medicines and brand name homeopathic medicines (specialties). BOIRON group centralizes its production and logistics in France. It also has 26 wholly-owned or leased distribution facilities in France and various offices in the countries where it has subsidiaries. Net sales are distributed geographically as follows: France (43.5%), Europe (24%), North America (27.5%) and other (5%).
Employees
2,499
Date Price Change Volume
26-08-12 €26.50 +1.53% 772
26-08-11 €26.10 -0.76% 21,624
26-08-10 €26.30 -3.31% 3,060
26-08-07 €27.20 0.00% 1,516
26-08-06 €27.20 -1.09% 1,960

Annual profits - Rate of surprise